{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:18:17Z","timestamp":1774073897660,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/jp.2016.47","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T05:08:04Z","timestamp":1464239284000},"page":"S32-S36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Challenges, priorities and novel therapies for hypoxemic respiratory failure and pulmonary hypertension in the neonate"],"prefix":"10.1038","volume":"36","author":[{"given":"J L","family":"Aschner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Gien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Ambalavanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P","family":"Kinsella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G G","family":"Konduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Lakshminrusimha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O D","family":"Saugstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R H","family":"Steinhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"BFjp201647_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199702273360902","volume":"336","author":"JD Roberts Jr","year":"1997","unstructured":"Roberts JD Jr, Fineman JR, Morin FC III, Shaul PW, Rimar S, Schreiber MD et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997; 336: 605\u2013610.","journal-title":"N Engl J Med"},{"key":"BFjp201647_CR2","doi-asserted-by":"crossref","unstructured":"Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Pediatrics 1997; 99: 838\u2013845.","DOI":"10.1542\/peds.99.6.838"},{"key":"BFjp201647_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1056\/NEJM200002173420704","volume":"342","author":"RH Clark","year":"2000","unstructured":"Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000; 342: 469\u2013474.","journal-title":"N Engl J Med"},{"key":"BFjp201647_CR4","doi-asserted-by":"crossref","unstructured":"Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. The Franco-Belgium Collaborative NO Trial Group. Lancet 1999; 354: 1066\u20131071.","DOI":"10.1016\/S0140-6736(99)03309-7"},{"key":"BFjp201647_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/jp.2009.171","volume":"30","author":"A Gonzalez","year":"2010","unstructured":"Gonzalez A, Fabres J, D'Apremont I, Urcelay G, Avaca M, Gandolfi C et al. Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension. J Perinatol 2010; 30: 420\u2013424.","journal-title":"J Perinatol"},{"key":"BFjp201647_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1542\/peds.113.3.559","volume":"113","author":"GG Konduri","year":"2004","unstructured":"Konduri GG, Solimano A, Sokol GM, Singer J, Ehrenkranz RA, Singhal N et al. A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. Pediatrics 2004; 113: 559\u2013564.","journal-title":"Pediatrics"},{"key":"BFjp201647_CR7","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/jp.2013.83","volume":"33","author":"GG Konduri","year":"2013","unstructured":"Konduri GG, Sokol GM, Van Meurs KP, Singer J, Ambalavanan N, Lee T et al. Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term\/late preterm neonates with moderate hypoxic respiratory failure. J Perinatol 2013; 33: 944\u2013949.","journal-title":"J Perinatol"},{"key":"BFjp201647_CR8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1542\/peds.97.1.48","volume":"97","author":"RD Findlay","year":"1996","unstructured":"Findlay RD, Taeusch HW, Walther FJ . Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996; 97: 48\u201352.","journal-title":"Pediatrics"},{"key":"BFjp201647_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0022-3476(98)70482-2","volume":"132","author":"A Lotze","year":"1998","unstructured":"Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH . Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr 1998; 132: 40\u201347.","journal-title":"J Pediatr"},{"key":"BFjp201647_CR10","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1513\/AnnalsATS.201312-424LD","volume":"11 Suppl 3","author":"CT McEvoy","year":"2014","unstructured":"McEvoy CT, Jain L, Schmidt B, Abman S, Bancalari E, Aschner JL . Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc 2014; 11 Suppl 3: S146\u2013S153.","journal-title":"Ann Am Thorac Soc"},{"key":"BFjp201647_CR11","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1513\/AnnalsATS.201409-414MG","volume":"12 Suppl 1","author":"GD Rubenfeld","year":"2015","unstructured":"Rubenfeld GD . Confronting the frustrations of negative clinical trials in acute respiratory distress syndrome. Ann Am Thorac Soc 2015; 12 Suppl 1: S58\u2013S63.","journal-title":"Ann Am Thorac Soc"},{"key":"BFjp201647_CR12","volume-title":"Sequential Medical Trials","author":"P Armitage","year":"1975","unstructured":"Armitage P . Sequential Medical Trials, 2nd ed. New York, USA: John Wiley & Sons, 1975."},{"key":"BFjp201647_CR13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1542\/peds.76.4.479","volume":"76","author":"RH Bartlett","year":"1985","unstructured":"Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB . Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 1985; 76: 479\u2013487.","journal-title":"Pediatrics"},{"key":"BFjp201647_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0022-3476(05)83341-4","volume":"117","author":"WA Carlo","year":"1990","unstructured":"Carlo WA, Siner B, Chatburn RL, Robertson S, Martin RJ . Early randomized intervention with high-frequency jet ventilation in respiratory distress syndrome. J Pediatr 1990; 117: 765\u2013770.","journal-title":"J Pediatr"},{"key":"BFjp201647_CR15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1542\/peds.82.4.527","volume":"82","author":"AT Shennan","year":"1988","unstructured":"Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM . Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527\u2013532.","journal-title":"Pediatrics"},{"key":"BFjp201647_CR16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe AH, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723\u20131729.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFjp201647_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1542\/peds.2004-0204","volume":"114","author":"MC Walsh","year":"2004","unstructured":"Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004; 114: 1305\u20131311.","journal-title":"Pediatrics"},{"key":"BFjp201647_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/jp.2015.19","volume":"35","author":"NL Maitre","year":"2015","unstructured":"Maitre NL, Ballard RA, Ellenberg JH, Davis SD, Greenberg JM, Hamvas A et al. Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach. J Perinatol 2015; 35: 313\u2013321.","journal-title":"J Perinatol"},{"key":"BFjp201647_CR19","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1513\/AnnalsATS.201504-218OC","volume":"12","author":"BB Poindexter","year":"2015","unstructured":"Poindexter BB, Feng R, Schmidt B, Aschner JL, Ballard RA, Hamvas A et al. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann Am Thorac Soc 2015; 12: 1822\u20131830.","journal-title":"Ann Am Thorac Soc"},{"key":"BFjp201647_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12887-015-0346-3","volume":"15","author":"GS Pryhuber","year":"2015","unstructured":"Pryhuber GS, Maitre NL, Ballard RA, Cifelli D, Davis SD, Ellenberg JH et al. Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States. BMC Pediatr 2015; 15: 37.","journal-title":"BMC Pediatr"},{"key":"BFjp201647_CR21","unstructured":"University of Pennsylvania; National Heart, Lung, and Blood Institute. Prematurity and Respiratory Outcomes Program (PROP). In: Clinicaltrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), 2011 [cited 2 Dec 2015]. Available from https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01435187?term=NCT01435187&rank=1 NLM. Identifier: NCT01435187."},{"key":"BFjp201647_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins FS, Varmus H . A new initiative on precision medicine. N Engl J Med 2015; 372: 793\u2013795.","journal-title":"N Engl J Med"},{"key":"BFjp201647_CR23","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1542\/neo.13-5-e281","volume":"13","author":"JP Palma","year":"2012","unstructured":"Palma JP, Benitz WE, Tarczy-Hornoch P, Butte AJ, Longhurst CA . Neonatal informatics: transforming neonatal care through translational bioinformatics. Neoreviews 2012; 13: e281\u2013e284.","journal-title":"Neoreviews"},{"key":"BFjp201647_CR24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/apa.12707","volume":"103","author":"CD Fike","year":"2014","unstructured":"Fike CD, Summar M, Aschner JL . L-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infants. Acta Paediatr 2014; 103: 1019\u20131026.","journal-title":"Acta Paediatr"},{"key":"BFjp201647_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1165\/rcmb.2014-0351OC","volume":"53","author":"CD Fike","year":"2015","unstructured":"Fike CD, Dikalova A, Kaplowitz MR, Cunningham G, Summar M, Aschner JL . Rescue treatment with L-citrulline inhibits hypoxia-induced pulmonary hypertension in newborn pigs. Am J Respir Cell Mol Biol 2015; 53: 255\u2013264.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFjp201647_CR26","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/nm.2544","volume":"17","author":"A Erez","year":"2011","unstructured":"Erez A, Nagamani SC, Shchelochkov OA, Premkumar MH, Campeau PM, Chen Y et al. Requirement of argininosuccinate lyase for systemic nitric oxide production. Nat Med 2011; 17: 1619\u20131626.","journal-title":"Nat Med"},{"key":"BFjp201647_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2125.2007.02990.x","volume":"65","author":"E Schwedhelm","year":"2008","unstructured":"Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol 2008; 65: 51\u201359.","journal-title":"Br J Clin Pharmacol"},{"key":"BFjp201647_CR28","doi-asserted-by":"publisher","first-page":"L506","DOI":"10.1152\/ajplung.00017.2009","volume":"297","author":"M Ananthakrishnan","year":"2009","unstructured":"Ananthakrishnan M, Barr FE, Summar ML, Smith HA, Kaplowitz M, Cunningham G et al. L-citrulline ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol 2009; 297: L506\u2013L511.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFjp201647_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1203\/PDR.0b013e3181f90278","volume":"68","author":"A Vadivel","year":"2010","unstructured":"Vadivel A, Aschner JL, Rey-Parra GJ, Magarik J, Zeng H, Summar M et al. L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats. Pediatr Res 2010; 68: 519\u2013525.","journal-title":"Pediatr Res"},{"key":"BFjp201647_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1164\/rccm.200907-1126OC","volume":"182","author":"RL Keller","year":"2010","unstructured":"Keller RL, Tacy TA, Hendricks-Munoz K, Xu J, Moon-Grady AJ, Neuhaus J et al. Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. Am J Respir Crit Care Med 2010; 182: 555\u2013561.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFjp201647_CR31","doi-asserted-by":"publisher","first-page":"H541","DOI":"10.1152\/ajpheart.00770.2006","volume":"293","author":"E B\u00fcssemaker","year":"2007","unstructured":"B\u00fcssemaker E, Pistrosch F, F\u00f6rster S, Herbrig K, Gross P, Passauer J et al. Rho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide. Am J Physiol Heart Circ Physiol 2007; 293: H541\u2013H547.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFjp201647_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/01.RES.0000246172.77441.f1","volume":"99","author":"R Chapados","year":"2006","unstructured":"Chapados R, Abe K, Ihida-Stansbury K, McKean D, Gates AT, Kern M et al. ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling. Circ Res 2006; 99: 837\u2013844.","journal-title":"Circ Res"},{"key":"BFjp201647_CR33","doi-asserted-by":"publisher","first-page":"L976","DOI":"10.1152\/ajplung.00512.2005","volume":"291","author":"TA Parker","year":"2006","unstructured":"Parker TA, Roe G, Grover TR, Abman SH . Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 2006; 291: L976\u2013L982.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFjp201647_CR34","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1165\/ajrcmb.25.5.4461","volume":"25","author":"Z Wang","year":"2001","unstructured":"Wang Z, Jin N, Ganguli S, Swartz DR, Li L, Rhoades RA . Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction. Am J Respir Cell Mol Biol 2001; 25: 628\u2013635.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFjp201647_CR35","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/01.RES.0000261658.12024.18","volume":"100","author":"M Oka","year":"2007","unstructured":"Oka M, Homma N, Taraseviciene-Stewart L, Morris KG, Kraskauskas D, Burns N et al. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats. Circ Res 2007; 100: 923\u2013929.","journal-title":"Circ Res"},{"key":"BFjp201647_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejphar.2004.11.047","volume":"507","author":"M L\u00f6hn","year":"2005","unstructured":"L\u00f6hn M, Steioff K, Bleich M, Busch AE, Ivashchenko Y . Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation. Eur J Pharmacol 2005; 507: 179\u2013186.","journal-title":"Eur J Pharmacol"},{"key":"BFjp201647_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/01.fjc.0000248244.64430.4a","volume":"48","author":"K Abe","year":"2006","unstructured":"Abe K, Tawara S, Oi K, Hizume T, Uwatoku T, Fukumoto Y et al. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice. J Cardiovasc Pharmacol 2006; 48: 280\u2013285.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFjp201647_CR38","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/FJC.0b013e3181593774","volume":"50","author":"N Homma","year":"2007","unstructured":"Homma N, Nagaoka T, Morio Y, Ota H, Gebb SA, Karoor V et al. Endothelin-1 and serotonin are involved in activation of RhoA\/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation. J Cardiovasc Pharmacol 2007; 50: 697\u2013702.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFjp201647_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/pr.2012.177","volume":"73","author":"J Gien","year":"2013","unstructured":"Gien J, Tseng N, Seedorf G, Roe G, Abman SH . Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep. Pediatr Res 2013; 73: 252\u2013262.","journal-title":"Pediatr Res"},{"key":"BFjp201647_CR40","doi-asserted-by":"publisher","first-page":"L299","DOI":"10.1152\/ajplung.00271.2013","volume":"306","author":"J Gien","year":"2014","unstructured":"Gien J, Tseng N, Seedorf G, Roe G, Abman SH . Peroxisome proliferator activated receptor-gamma-Rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2014; 306: L299\u2013L308.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFjp201647_CR41","doi-asserted-by":"publisher","first-page":"L1031","DOI":"10.1152\/ajplung.90392.2008","volume":"296","author":"C Dasgupta","year":"2009","unstructured":"Dasgupta C, Sakurai R, Wang Y, Guo P, Ambalavanan N, Torday JS et al. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol 2009; 296: L1031\u2013L1041.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFjp201647_CR42","doi-asserted-by":"publisher","first-page":"L125","DOI":"10.1152\/ajplung.00074.2011","volume":"301","author":"T Nicola","year":"2011","unstructured":"Nicola T, Ambalavanan N, Zhang W, James ML, Rehan V, Halloran B et al. Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Am J Physiol Lung Cell Mol Physiol 2011; 301: L125\u2013L134.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFjp201647_CR43","first-page":"H1483","volume":"268","author":"RH Steinhorn","year":"1995","unstructured":"Steinhorn RH, Russell JA, Morin FC III . Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension. Am J Physiol 1995; 268: H1483\u2013H1489.","journal-title":"Am J Physiol"},{"key":"BFjp201647_CR44","doi-asserted-by":"publisher","first-page":"L755","DOI":"10.1152\/ajplung.00138.2010","volume":"301","author":"M Chester","year":"2011","unstructured":"Chester M, Seedorf G, Tourneux P, Gien J, Tseng N, Grover T et al. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2011; 301: L755\u2013L764.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFjp201647_CR45","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1164\/rccm.200605-676OC","volume":"174","author":"S Lakshminrusimha","year":"2006","unstructured":"Lakshminrusimha S, Russell JA, Wedgwood S, Gugino SF, Kazzaz JA, Davis JM et al. Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med 2006; 174: 1370\u20131377.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFjp201647_CR46","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/PCC.0b013e31816c7035","volume":"9","author":"RB Tessler","year":"2008","unstructured":"Tessler RB, Zadinello M, Fiori H, Colvero M, Belik J, Fiori RM . Tadalafil improves oxygenation in a model of newborn pulmonary hypertension. Pediatr Crit Care Med 2008; 9: 330\u2013332.","journal-title":"Pediatr Crit Care Med"},{"key":"BFjp201647_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jpeds.2014.03.059","volume":"165","author":"SN Acker","year":"2014","unstructured":"Acker SN, Kinsella JP, Abman SH, Gien J . Vasopressin improves hemodynamic status in infants with congenital diaphragmatic hernia. J Pediatr 2014; 165: 53\u201358.","journal-title":"J Pediatr"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp201647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp201647","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp201647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:03:02Z","timestamp":1744174982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp201647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":47,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFjp201647"],"URL":"https:\/\/doi.org\/10.1038\/jp.2016.47","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"15 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JLA, JG, NA, JPK, GGK, SL, ODS and RHS received honoraria for their participation in a roundtable meeting supported by a grant from Mallinckrodt Pharmaceuticals, formerly Ikaria. JLA is named on an intellectual property rights patent for the use of intravenous citrulline for neonatal lung diseases. NA has received research support from Pfizer and has received research support as a mentor from Ikaria. GGK has received consulting fees from Boston Health Economics and Actelion Clinical Research. SL was a member of the speaker\u2019s bureau for Ikaria from June 2010 to October 2014 and has received grant support from the American Academy of Pediatrics and Canadian Pediatric Society. RHS has received research grant support from Pfizer. NIH Grants: 1U01HL101456 (JLA); U01 HL122626 and R01 HD067126 (NA); 5R01HD072929-03 (SL); 5R01HL057268-11 (GGK); 5R01HL054705-13 (RHS).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}